You must enable your browser's JavaScript functions, in order to fully utilize the Certaindri.com website.

For more information on how we use JavaScript and Cookies to improve your user experience, please read here.

$60 for 60 Years Donors ** Naomi Prever ** Gladys B. Lipkin ** Rita Miller ** JoAnne Goldberg **  Ann Stern **  $60 for 60 Years Donors ** Rita Seiff  ** Diane Stewart ** Gloria Supran ** Hannah and Stan Scheff  ** Sherrie Bieber **  $60 for 60 Years Donors ** Trudy and Joel Balizer ** Joan Klein ** Rayna Becker ** Roselyn Kessler ** Helene Riffle ** $60 for 60 Years Donors ** The Board of Valencia Palms ** All The Members of Valencia Palms ** Melody Iden **  Hally Shaw ** Joyce Wallach ** Rita Feuerstadt **  $60 for 60 Years Donors ** Boca West Chapter ** Arlene Dworkis ** Woodfield Chapter  ** Alfred Chiuchiolo ** Doreen Berman ** Jeffrey Schachter **

Breakthroughs

Category:

FDA Grants IND* to Investigator at University Of Miami School of Medicine for Phase 2 Trial with AEZS-108 in

Published Friday, November 11, 2011
FDA Grants IND* to Investigator at University Of Miami School of Medicine for Phase 2 Trial with AEZS-108 in Triple-Negative Breast Cancer Aeterna Zentaris Inc. (a late-stage oncology drug development company) recently announced that the U.S.Food and Drug Administration (FDA) has granted Alberto J. Montero, M.D., Assistant Professor, Department of more»

Research Cures Cancer

Published Tuesday, November 8, 2011
Sylvester is leading the way in cancer research, treatment, and prevention. Its teams of cancer experts have developed or are pioneering among the most innovative strategies to fight some of the most aggressive and deadly forms of cancer. Below are examples of the efforts of Sylvester’s brilliant research teams. Bladder Cancer Dr. Vinata Lokeshwar has more»

Miami Teen Battles Ovarian Cancer

Published Wednesday, November 2, 2011

UM JOINS EXCLUSIVE MULTI-CENTER GROUP IN PHASE II CLINICAL TRIAL OF IMPORTANT NEW TREATMENT TECHNIQUE

UM JOINS EXCLUSIVE MULTI-CENTER GROUP IN PHASE II CLINICAL TRIAL OF IMPORTANT NEW TREATMENT TECHNIQUE The University of Miami will be joining an exclusive multi-center group to complete phase II of a clinical trial using heat shock protein vaccine (HSPPC-96) for patients with newly diagnosed glioblastoma multiforme (GBM).1 The trial revolves around more»

Items 1-4 of 4